Intravitreal Celecoxib for Chronic Uveitis: A Phase I Investigational Safety Study

Trial Profile

Intravitreal Celecoxib for Chronic Uveitis: A Phase I Investigational Safety Study

Discontinued
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Uveitis
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Feb 2017 Status changed from not yet recruiting to discontinued.
    • 08 Dec 2015 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov.
    • 08 Dec 2015 Planned initiation date changed from 1 May 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top